The most recent covid relief law offered federal funding to pay insurance premiums for workers who lost their jobs and opted to keep their workplace insurance through COBRA. But the window to take advantage of the subsidized coverage is closing: Many workers would need to enroll in the program by July 31.
At a pop-up vaccine clinic in a McDonald’s parking lot in the city of San Bernardino, fewer than two dozen people agreed to get a shot, offering a snapshot of the faltering vaccination effort.
While covid is generally mild in children, doctors report a growing number of long-haul covid symptoms and MIS-C cases, particularly among Black and Latino children.
With covid cases on the upswing again around the country, partisan division remains over how to address the pandemic. Meanwhile, the Biden administration proposes bigger penalties for hospitals that fail to make their prices public as required. Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Tami Luhby of CNN join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite stories of the week they think you should read, too.
Unvaccinated Westerners are flocking to movie theaters, malls and other indoor spaces to beat the smoke and heat. Health officials worry that may fuel covid outbreaks.
The major sports leagues are struggling to vaccinate enough of their players to protect the clubhouse and locker room, and few stars have stepped forward to pitch vaccination to teammates or fans. WNBA players are an exception, with a 99% vaccination rate and high-profile ads urging the public to get vaccinated.
In today’s pharmaceutical universe, a simple “safe and effective” determination by the Food and Drug Administration to approve a drug can be manipulated to sell products of questionable value. And drugmakers can profit handsomely,
At the center of the nation’s delta variant outbreak, public health efforts are mired in a political turf war.
After being mostly closed to the public and the press for more than a year, California’s state Capitol is open again — masks, temperature checks, covid outbreaks and all.
Novavax is a vaccine company that, despite $2 billion in new federal and international funding, still hasn’t come through with a licensed covid vaccine. It hopes it can still help to fight the global covid scourge, but will it deliver?
